Linked Data API

Show Search Form

Search Results

1604244
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-28more like thismore than 2023-03-28
date less than 2023-03-14more like thismore than 2023-03-14
date tabled less than 2023-03-14more like thismore than 2023-03-14
ddp created less than 2023-03-14T22:16:37.487Zmore like thismore than 2023-03-14T22:16:37.487Z
answering body
Department for Business and Trade more like this
question status Tabled more like this
answering dept id 214 more like this
answering dept short name Business and Trade more like this
answering dept sort name Business and Trade more like this
ddp modified
less than 2023-03-14T22:26:18.847Zmore like thismore than 2023-03-14T22:26:18.847Z
less than 2023-05-10T14:12:18.259Zmore like thismore than 2023-05-10T14:12:18.259Z
hansard heading Supermarkets: Competition more like this
house id 2 remove filter
identifier HL6471 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-05-10T13:40:27.59Zmore like thismore than 2023-05-10T13:40:27.59Z
question text To ask His Majesty's Government what estimate they have made of how many actions have been brought by small-scale growers of fruit and vegetables against alleged unfair practices pursued by supermarkets following the recent interruptions to the supply chain; and how many of these actions have culminated in fines where growers were found to have been disadvantaged by the supermarkets. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Baroness McIntosh of Pickering more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6471 more like this
type
WrittenParliamentaryQuestion
uin HL6471 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
384
label Biography information for Baroness McIntosh of Pickering more like this
publisher
25277
pref label House of Lords more like this
tabling member
384
label Biography information for Baroness McIntosh of Pickering more like this
1601503
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-20more like thismore than 2023-03-20
date less than 2023-03-06more like thismore than 2023-03-06
date tabled less than 2023-03-06more like thismore than 2023-03-06
ddp created less than 2023-03-06T22:07:02.760Zmore like thismore than 2023-03-06T22:07:02.760Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-06T22:17:21.404Zmore like thismore than 2023-03-06T22:17:21.404Z
less than 2023-04-17T13:50:20.265Zmore like thismore than 2023-04-17T13:50:20.265Z
hansard heading Integrated Care Systems: Finance more like this
house id 2 remove filter
identifier HL6157 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-17T13:50:05.293Zmore like thismore than 2023-04-17T13:50:05.293Z
question text To ask His Majesty's Government which Integrated Care Systems are forecast to be in debt at the end of the 2022–23 financial year. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Baroness Merron more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6157 more like this
type
WrittenParliamentaryQuestion
uin HL6157 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
347
label Biography information for Baroness Merron more like this
publisher
25277
pref label House of Lords more like this
tabling member
347
label Biography information for Baroness Merron more like this
1601505
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-20more like thismore than 2023-03-20
date less than 2023-03-06more like thismore than 2023-03-06
date tabled less than 2023-03-06more like thismore than 2023-03-06
ddp created less than 2023-03-06T22:07:05.193Zmore like thismore than 2023-03-06T22:07:05.193Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-06T22:17:23.817Zmore like thismore than 2023-03-06T22:17:23.817Z
less than 2023-04-17T13:50:18.612Zmore like thismore than 2023-04-17T13:50:18.612Z
hansard heading Integrated Care Systems: Finance more like this
house id 2 remove filter
identifier HL6158 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-17T13:50:05.333Zmore like thismore than 2023-04-17T13:50:05.333Z
question text To ask His Majesty's Government which Integrated Care Systems have submitted draft operating plans forecasting that they will have no deficit at the end of the 2023–24 financial year. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Baroness Merron more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6158 more like this
type
WrittenParliamentaryQuestion
uin HL6158 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
347
label Biography information for Baroness Merron more like this
publisher
25277
pref label House of Lords more like this
tabling member
347
label Biography information for Baroness Merron more like this
1604684
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:52:10.810Zmore like thismore than 2023-03-15T21:52:10.810Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-15T21:56:31.489Zmore like thismore than 2023-03-15T21:56:31.489Z
less than 2023-04-12T12:04:15.154Zmore like thismore than 2023-04-12T12:04:15.154Z
hansard heading Evusheld more like this
house id 2 remove filter
identifier HL6531 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-12T11:32:54.787Zmore like thismore than 2023-04-12T11:32:54.787Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 6 March (HL5937), why the National Institute for Clinical Excellence (NICE) request for referral of 8 June is described as for “referral of Evusheld for treatment of COVID-19” but, as confirmed in a NICE freedom of information response, the request was for “referral of tixagevimab-cilgavimab for preventing COVID-19 [ID6136] on 8 June 2022”, causing delay to the possibility of a decision at a time when the preventative prophylaxis Evusheld was highly efficacious. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Mendelsohn more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6531 more like this
type
WrittenParliamentaryQuestion
uin HL6531 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4286
label Biography information for Lord Mendelsohn more like this
publisher
25277
pref label House of Lords more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1604679
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:52:01.777Zmore like thismore than 2023-03-15T21:52:01.777Z
answering body
Department for Business and Trade more like this
question status Tabled more like this
answering dept id 214 more like this
answering dept short name Business and Trade more like this
answering dept sort name Business and Trade more like this
ddp modified
less than 2023-03-15T21:56:18.434Zmore like thismore than 2023-03-15T21:56:18.434Z
less than 2023-04-11T15:10:18.334Zmore like thismore than 2023-04-11T15:10:18.334Z
hansard heading Groceries Code Adjudicator more like this
house id 2 remove filter
identifier HL6526 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-11T14:38:29.39Zmore like thismore than 2023-04-11T14:38:29.39Z
question text To ask His Majesty's Government what is the timetable for the review of the role of the Grocery Code adjudicator; and how Parliament will be notified of the outcome. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Baroness Jones of Whitchurch more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6526 more like this
type
WrittenParliamentaryQuestion
uin HL6526 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
3792
label Biography information for Baroness Jones of Whitchurch more like this
publisher
25277
pref label House of Lords more like this
tabling member
3792
label Biography information for Baroness Jones of Whitchurch more like this
1604683
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:52:08.973Zmore like thismore than 2023-03-15T21:52:08.973Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-15T21:56:29.006Zmore like thismore than 2023-03-15T21:56:29.006Z
less than 2023-04-11T12:40:45.457Zmore like thismore than 2023-04-11T12:40:45.457Z
hansard heading Coronavirus: Immunosuppression more like this
house id 2 remove filter
identifier HL6530 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-11T12:09:24.917Zmore like thismore than 2023-04-11T12:09:24.917Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 March (HL5824), which body will assume responsibility for ensuring that the immunocompromised will continue to be treated as a priority after the disbanding of the Antivirus and Therapeutics Taskforce, and its related programme and strategy boards. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Mendelsohn more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6530 more like this
type
WrittenParliamentaryQuestion
uin HL6530 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4286
label Biography information for Lord Mendelsohn more like this
publisher
25277
pref label House of Lords more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1604694
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:52:34.277Zmore like thismore than 2023-03-15T21:52:34.277Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-15T21:57:13.120Zmore like thismore than 2023-03-15T21:57:13.120Z
less than 2023-04-06T14:37:14.240Zmore like thismore than 2023-04-06T14:37:14.240Z
hansard heading Coronavirus: Screening more like this
house id 2 remove filter
identifier HL6542 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-06T14:36:46.35Zmore like thismore than 2023-04-06T14:36:46.35Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 8 February (HL5061), when data for April 2022 and beyond will be validated for release; and on what grounds this information is commercially sensitive. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Strathcarron more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6542 more like this
type
WrittenParliamentaryQuestion
uin HL6542 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4937
label Biography information for Lord Strathcarron more like this
publisher
25277
pref label House of Lords more like this
tabling member
4937
label Biography information for Lord Strathcarron more like this
1599737
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-13more like thismore than 2023-03-13
date less than 2023-02-27more like thismore than 2023-02-27
date tabled less than 2023-02-27more like thismore than 2023-02-27
ddp created less than 2023-02-27T23:06:28.240Zmore like thismore than 2023-02-27T23:06:28.240Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-02-27T23:18:25.502Zmore like thismore than 2023-02-27T23:18:25.502Z
less than 2023-04-05T15:19:14.220Zmore like thismore than 2023-04-05T15:19:14.220Z
hansard heading Evusheld more like this
house id 2 remove filter
identifier HL5936 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-05T14:48:03.37Zmore like thismore than 2023-04-05T14:48:03.37Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 7 February (HL4942) which confirmed that the expert working group established specifically to review Evusheld pre-exposure prophylaxis only met twice, the last meeting being on 19 May 2022, why the parliamentary Written Answers provided from that date until 4 July 2022 refer to asking clinicians to advise on the most appropriate option; and what other advice was being received during this period. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Mendelsohn more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL5936 more like this
type
WrittenParliamentaryQuestion
uin HL5936 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4286
label Biography information for Lord Mendelsohn more like this
publisher
25277
pref label House of Lords more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1604682
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:52:07.117Zmore like thismore than 2023-03-15T21:52:07.117Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-15T21:56:26.445Zmore like thismore than 2023-03-15T21:56:26.445Z
less than 2023-04-05T15:20:18.475Zmore like thismore than 2023-04-05T15:20:18.475Z
hansard heading Coronavirus: Medical Treatments more like this
house id 2 remove filter
identifier HL6529 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-05T14:49:00.787Zmore like thismore than 2023-04-05T14:49:00.787Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 7 March 2023 (HL5695), to which body the recommendations on the relevant cohorts for COVID-19 therapeutics are to be made, as discussed by the Chair of the Therapeutics Clinical Review Panel on 2 February; and whether the preparation of these recommendations included reviewing details within the report Qcovid 4 - Predicting risk of death or hospitalisation from COVID-19, published in August 2022. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Mendelsohn more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6529 more like this
type
WrittenParliamentaryQuestion
uin HL6529 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4286
label Biography information for Lord Mendelsohn more like this
publisher
25277
pref label House of Lords more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this
1604709
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2023-03-29more like thismore than 2023-03-29
date less than 2023-03-15more like thismore than 2023-03-15
date tabled less than 2023-03-15more like thismore than 2023-03-15
ddp created less than 2023-03-15T21:56:04.843Zmore like thismore than 2023-03-15T21:56:04.843Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2023-03-15T22:05:26.057Zmore like thismore than 2023-03-15T22:05:26.057Z
less than 2023-04-05T15:20:19.959Zmore like thismore than 2023-04-05T15:20:19.959Z
hansard heading Coronavirus: Immunosuppression more like this
house id 2 remove filter
identifier HL6532 more like this
legislature
25277
pref label House of Lords more like this
parliament number 58 more like this
question first answered
less than 2023-04-05T14:48:38.823Zmore like thismore than 2023-04-05T14:48:38.823Z
question text To ask His Majesty's Government, further to the Written Answer by Lord Markham on 14 March (HL5699), and as set out in the attachment to the Written Answer NICE nMABs appraisal committee paper, what assessment they have made of the finding that the prioritised list of people with conditions for which it may be clinically advantageous to receive neutralising monoclonal antibodies prophylaxis numbers 1.8 million. more like this
session
2022/23 more like this
session number 3 more like this
tabling member printed
Lord Mendelsohn more like this
title House of Lords Tabled Parliamentary Question 2022/23 HL6532 more like this
type
WrittenParliamentaryQuestion
uin HL6532 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4286
label Biography information for Lord Mendelsohn more like this
publisher
25277
pref label House of Lords more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this